Evidence map›Paper›PMID 37049649›Full record

ArticleMolecules (Basel, Switzerland)2023

Triphenylamine-Containing Benzoic Acids: Synthesis, Liquid Crystalline and Redox Properties.

Beatriz Feringán, Alejandro Martínez-Bueno, Teresa Sierra, Raquel Giménez

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Beatriz FeringánInstituto de Nanociencia y Materiales de Aragón (INMA), Departamento de Química Orgánica, Facultad de Ciencias, CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.
Alejandro Martínez-BuenoInstituto de Nanociencia y Materiales de Aragón (INMA), Departamento de Química Orgánica, Facultad de Ciencias, CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.
Teresa SierraInstituto de Nanociencia y Materiales de Aragón (INMA), Departamento de Química Orgánica, Facultad de Ciencias, CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0001-7091-077X
Raquel GiménezInstituto de Nanociencia y Materiales de Aragón (INMA), Departamento de Química Orgánica, Facultad de Ciencias, CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.
Universidad de Zaragoza · ES

Funding

Gobierno de Aragón E47_20R research groupGovernment of Spain projects PGC2018-093761-B-C31, PID2021-122882NB-I00, PID2021-126132NB-I00 MCIN/ AEI/10.13039/501100011033/ and FEDER "Una manera de hacer Europa"
6 · The paper itself

Abstract

The synthesis, characterization and liquid crystalline and electrochemical properties of novel triarylamines, in which the triphenylamine platform is non-symmetrically modified with a 4-(6-oxyhexyloxy)benzoic acid group, are reported. Compounds show columnar liquid crystalline behavior, as confirmed through the use of polarized optical microscopy, differential scanning calorimetry and X-ray diffraction. Electrochemical properties were measured using cyclic voltammperometry, obtaining low oxidation potentials and HOMO values that were optimum for consideration as organic semiconductors in hole transport layers. In addition, the photoredox activity of one of these derivatives in dichloromethane was studied under light irradiation. A photooxidation/assembly process under white light irradiation occurs without the assistance of hydrogen bonding amide functional groups.

Indexed as

electroactivehole transporthydrogen bondliquid crystalorganic semiconductorphotoactiveredoxtriphenylamine

Identifiers

PMID37049649
PMCPMC10096164
OpenAlexW4360865016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.